Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | |
| Sales | 10,645 | 2,057 |
| Cost of Goods | 5,681 | 258 |
| Gross Profit | 4,964 | 1,799 |
| Operating Expenses | 27,556 | 17,828 |
| Operating Income | -21,911 | -15,771 |
| Interest Expense | 421 | 421 |
| Other Income | -61 | -845 |
| Pre-tax Income | -22,393 | -17,037 |
| Net Income Continuous | -22,393 | -17,037 |
| Net Income | $-22,393 | $0 |
| EPS Basic Total Ops | -10.47 | -14.06 |
| EPS Basic Continuous Ops | -10.33 | -13.82 |
| EPS Diluted Total Ops | -10.47 | -14.06 |
| EPS Diluted Continuous Ops | -10.33 | -13.82 |
| EPS Diluted Before Non-Recurring Items | 1.63 | N/A |
| EBITDA(a) | $-19,017 | $-14,251 |